Spots Global Cancer Trial Database for hematopoietic stem cell transplantation
Every month we try and update this database with for hematopoietic stem cell transplantation cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Healthy Donor Study II - Comparing Plerixafor With G-CSF and Plerixafor | NCT01403896 | Malignant Lymph... | Plerixafor (Moz... Plerixafor + G-... | 18 Years - 30 Years | Nova Scotia Health Authority | |
| Sirolimus/Tacrolimus Combination After HLA Matched Related Peripheral Blood Stem Cell Transplants | NCT01488253 | Acute Leukemia ... Myelodysplastic... Leukemia, Myelo... Leukemia, Myelo... | Sirolimus Tacrolimus | 20 Years - 60 Years | The Korean Society of Blood and Marrow Transplantation | |
| MRD-directed Donor Lymphocyte Infusion for Reduce of Relapse After Allo-HSCT | NCT02673008 | Minimal Residua... Donor Lymphocyt... Hematopoietic S... Relapse | donor lymphocyt... | 14 Years - 65 Years | Nanfang Hospital, Southern Medical University | |
| Associations Between Pre-transplant Comorbidities and Post-transplant Toxicities and Quality of Life | NCT01930981 | Hematologic Mal... Other Diagnoses... | 19 Years - | Fred Hutchinson Cancer Center | ||
| Fast-track Blood Test for Suspected Fever by Deficiency of a Kind of White Blood Cells As Main Defense Against Infection | NCT05393505 | Neutropenic Fev... | Meropenem Injec... Levofloxacin Amoxicillin Cla... Antibiotic | 18 Years - | The University of Hong Kong | |
| An Efficacy and Safety Study of Azacitidine Subcutaneous in Combination With Durvalumab (MEDI4736) in Previously Untreated Adults With Higher-Risk Myelodysplastic Syndromes (MDS) or in Elderly Patients With Acute Myeloid Leukemia (AML) | NCT02775903 | Leukemia, Myelo... Myelodysplastic... | Azacitidine Durvalumab | 18 Years - | Celgene | |
| Ambulatory Physical Exercise Program in Hematopoietic Stem Cell Transplantation Recipients | NCT00402753 | Hematopoietic S... | Ambulatory Phys... | 18 Years - 70 Years | University of Zurich | |
| Sorafenib for Prophylaxis of Leukemia Relapse in Allo-HSCT Recipients With FLT3-ITD Positive AML | NCT02474290 | Acute Myeloid L... Hematopoietic S... | Sorafenib | 18 Years - 60 Years | Nanfang Hospital, Southern Medical University | |
| Cultural Tailoring and Pilot Testing of an Inpatient Yoga Therapy Program for Cancer Patients Undergoing Hematopoietic Stem Cell Transplantation in India, Tanzania, and the United States | NCT05681026 | Hematopoietic S... Cancer | Yoga Sessions Questionnaries Interviews | 18 Years - | M.D. Anderson Cancer Center | |
| Intensified Conditioning Regimen With High-Dose-Etoposide for Allo-HSCT for Adult Acute Lymphoblastic Leukemia | NCT01457040 | Acute Lymphobla... Stem Cell Trans... | TBI+CY+VP-16 FA+TBI+CY+VP-16 | 14 Years - 65 Years | Nanfang Hospital, Southern Medical University | |
| Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic Malignancies | NCT01341301 | Hematologic Mal... | Total Body Irra... Donor Lymphocyt... Cyclophosphamid... Tacrolimus Mycophenolate m... Allogeneic hema... Laboratory biom... | 18 Years - | Thomas Jefferson University | |
| Ixazomib in the Prophylaxis of Chronic Graft-versus-host Disease. | NCT03225417 | Hematopoietic S... Multiple Myelom... | Ixazomib Tacrolimus Sirolimus Any prophylaxis... | 18 Years - | Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | |
| Cellular Therapy With Cord Blood Cells | NCT00427557 | Multiple Myelom... Leukemia Lymphoma | Fludarabine Melphalan Umbilical Cord ... Rituximab Peripheral Bloo... | - 80 Years | M.D. Anderson Cancer Center | |
| Aza-Ven Followed by Reduced Toxicity Conditioning Regimen (MBF) as Salvage Therapy for Refractory AML. | NCT04904237 | Refractory Acut... | Aza-Ven-allo-HS... | 16 Years - 65 Years | Shanghai Jiao Tong University School of Medicine | |
| Photobiomodulation for Oral Mucositis and Functional Impairments During Hematopoietic Stem Cell Transplantation | NCT06260111 | Hematologic Can... | Photobiomodulat... Usual care | 18 Years - 70 Years | Universidad del Desarrollo | |
| Impact of Oral Nutritional Supplements on Patients Undergoing Haematopoietic Stem Cell Transplantation | NCT05460013 | Haematological ... | Traditional Con... Oral Nutritiona... | 18 Years - 75 Years | RenJi Hospital | |
| Targeted Busulfan, Fludarabine, Etoposide Conditioning Regimen for HSCT in Childhood and Adolescent ALL. | NCT02047578 | Acute Lymphobla... | Busulfan | - 21 Years | Seoul National University Hospital | |
| Hematopoietic Stem Cell Therapy for Patients With Refractory Myasthenia Gravis | NCT00424489 | Myasthenia Grav... | Hematopoietic S... Cyclophosphamid... ATG (rabbit) Mesna Methylprednisol... G-CSF | 15 Years - 65 Years | Northwestern University | |
| Anakinra: Efficacy in the Management of Fever During Neutropenia and Mucositis in ASCT - A Randomized Controlled Trial | NCT04099901 | Multiple Myelom... | Anakinra Placebos | 18 Years - | Radboud University Medical Center | |
| A Russian Prospective Observational Study of Invasive Fungal Infections in Patients With Acute Leukemia and Hematopoietic Stem Cell Transplantation | NCT01519648 | Invasive Fungal... | 1 Year - 95 Years | National Hematological Society, Russia | ||
| Effects of Digital Stories Intervention on Psychosocial Well-being | NCT03654599 | Bone Marrow Tra... Information Dis... Hematopoietic S... Psychosocial He... Depression Anxiety Stress Narrative | Baseline Survey... Digital Stories... Information Con... | 18 Years - | Arizona State University | |
| Study With Azacitidine in Pediatric Subjects With Newly Diagnosed Advanced Myelodysplastic Syndrome (MDS) and Juvenile Myelomonocytic Leukemia (JMML) | NCT02447666 | Myelodysplastic... Leukemia, Myelo... | Azacitidine | 1 Month - 18 Years | Celgene | |
| The Association of Microbiota Composition With cGVHD After Allo-HSCT | NCT05355675 | Hematopoietic S... Hematologic Mal... Chronic Graft-v... Complication | blood sample stool sample | 18 Years - 65 Years | First Affiliated Hospital of Zhejiang University | |
| Ambulatory Physical Exercise Program in Hematopoietic Stem Cell Transplantation Recipients | NCT00402753 | Hematopoietic S... | Ambulatory Phys... | 18 Years - 70 Years | University of Zurich | |
| Infliximab Efficacy, TDM and Serum TNFα Levels in Pediatric HSCT Recipients With aGVHD: Prospective Observational Study | NCT05362630 | Graft Versus Ho... Hematopoietic S... | - 18 Years | University of Pisa | ||
| Effect of Angiotensin Converting Enzyme and Sacubitril Valsartan in Patients After Bone Marrow Transplantation | NCT04092309 | Hematopoietic S... Cardiotoxicity | ACE inhibitor, ... | 18 Years - | University of Athens | |
| Mesenchymal Stem Cell Infusion in Haploidentical Hematopoietic Stem Cell Transplantation in Patients With Hematological Malignancies | NCT03106662 | Hematopoietic S... | mesenchymal ste... cyclophosphamid... | 18 Years - | Ankara University | |
| Administration of Rapidly Generated Multivirus-specific Cytotoxic T-Lymphocytes (VIRAGE) | NCT01070797 | Adenovirus Infe... Epstein-Barr Vi... Cytomegalovirus... Stem Cell Trans... | Multi-virus Spe... | - | Baylor College of Medicine | |
| Haploidentical Hematopoietic Stem Cell Transplantation for Acute Leukemias | NCT02759822 | Leukemia, Myelo... Precursor Cell ... | Haploidentical ... | 1 Year - 60 Years | Instituto Nacional de Cancer, Brazil | |
| Haplo-identical HSCT Versus Chemotherapy for Adult Acute Lymphoblastic Leukemia Patients | NCT02042690 | Acute Lymphobla... | Haplo-identical... Chemotherapy | 18 Years - 39 Years | Peking University | |
| Clinical Study of rATG Individualized Administration in Haploidentical Hematopoietic Stem Cell Transplantation | NCT05634915 | Hematopoietic S... Acute Leukemia | Individual ATG ATG | 16 Years - 60 Years | The First Affiliated Hospital of Soochow University | |
| Hematopoietic Stem Cell Transplantation in Myeloma | NCT00415987 | Multiple Myelom... | Hematopoietic S... | 18 Years - 65 Years | Azienda Ospedaliera San Giovanni Battista | |
| Cellular Therapy With Cord Blood Cells | NCT00427557 | Multiple Myelom... Leukemia Lymphoma | Fludarabine Melphalan Umbilical Cord ... Rituximab Peripheral Bloo... | - 80 Years | M.D. Anderson Cancer Center | |
| Anakinra: Efficacy in the Management of Fever During Neutropenia and Mucositis in ASCT - A Randomized Controlled Trial | NCT04099901 | Multiple Myelom... | Anakinra Placebos | 18 Years - | Radboud University Medical Center | |
| Exercise in Pediatric Autologous Stem Cell Transplant Patients | NCT01666015 | Cancer Autologous Hema... | EXERCISE (EX) Standard Care | 5 Years - 18 Years | University of Calgary | |
| Precision-T: A Randomized Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies | NCT05316701 | Acute Myeloid L... Acute Lymphoid ... Mixed Phenotype... Undifferentiate... Myelodysplastic... Acute Leukemia Therapy-Related... | Orca-T Standard-of-Car... | 18 Years - 65 Years | Orca Biosystems, Inc. | |
| Erythropoietin in the Treatment of Anemia After Autologous Hematopoietic Stem Cell Transplantation | NCT03010579 | Anemia Lymphoma Hematopoietic S... | erythropoietin iron supplement... | 18 Years - 65 Years | Peking University | |
| Monitoring and Treatment of Relapsed Leukemia Following Allogeneic Hematopoietic Stem Cell Transplantation in Children | NCT02484261 | Leukemia | Bortezomib Pravastatin | 22 Months - 21 Years | Children's National Research Institute | |
| Haplo HCT vs Haplo-cord HCT for Patients With AML | NCT03719534 | Hematopoietic S... Haplo-identical... Cord Blood Unit Acute Myeloid L... | haplo-HCT haplo-cord HCT | 18 Years - 60 Years | The First Affiliated Hospital of Soochow University | |
| Intravenous Administration of RGI-2001 in Patient Undergoing Allogenic Hematopoietic Stem Cell Transplantation (AHSCT) | NCT01379209 | Graft Versus Ho... | RGI-2001 Calcineurin Inh... Allogeneic Hema... Conditioning Re... Allogeneic Bone... Methotrexate Mofetil Mycophe... sirolimus | 18 Years - | Regimmune Corporation | |
| Phase I Study of CTL Anti-DP Infusion Post-hematopoietic Stem Cell Transplantation | NCT04180059 | Haematologic Di... | CTL 19 | 18 Years - 75 Years | Nantes University Hospital | |
| SCT in Ph Positive Acute Lymphoblastic Leukemia | NCT03821727 | Philadelphia Po... SCT | Hematopoietic S... | 18 Years - | University Hospital, Udine, Italy | |
| The "Light for the Brain" Study | NCT02677987 | Hematopoietic S... Cognitive Impai... Sleep Depression Fatigue Quality of Life | Intervention sy... Comparison syst... | 21 Years - | Northwestern University | |
| Mobile CARE-App to Promote Coping for Caregivers of Patients Receiving Stem Cell Transplant | NCT05709912 | Bone Marrow Tra... Hematologic Mal... | CARE Applicatio... Usual Care | 18 Years - | Massachusetts General Hospital | |
| A Research Study of Bone Marrow Transplantation From Unrelated or Partially Matched Related Donors | NCT01349101 | Hematological M... | Total Body Irra... Cyclophosphamid... Tacrolimus Mycophenolate m... Fludarabine Busulfan Hematopoietic s... | 18 Years - | Thomas Jefferson University | |
| C-CAR011 Treatment in Subjects With ALL After HSCT | NCT03327285 | Acute Lymphobla... | C-CAR011 | 15 Years - 65 Years | Peking University People's Hospital | |
| Chronic Graft-versus-host Disease (cGvHD) Prophylaxis With or Without ATG Prior to Stem Cell Transplantation (SCT) From HLA-identical Siblings in Patients With Acute Leukemia | NCT00678275 | Acute Myeloid L... Acute Lymphobla... | ATG FRESENIUS (... ATG FRESENIUS (... | 18 Years - 65 Years | Universitätsklinikum Hamburg-Eppendorf | |
| Clofarabine, Cytarabine, and Thymoglobulin for Allogeneic Transplantation | NCT00593645 | Myelodysplastic... Acute Myeloid L... | Clofarabine Cytarabine Thymoglobulin Stem cell infus... | 18 Years - | Washington University School of Medicine | |
| Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors | NCT01608152 | Leukemia Lymphoma | Focus Group Internet-Based ... Interview | 15 Years - 39 Years | M.D. Anderson Cancer Center | |
| Infliximab Efficacy, TDM and Serum TNFα Levels in Pediatric HSCT Recipients With aGVHD: Prospective Observational Study | NCT05362630 | Graft Versus Ho... Hematopoietic S... | - 18 Years | University of Pisa | ||
| MRD-directed Donor Lymphocyte Infusion for Reduce of Relapse After Allo-HSCT | NCT02673008 | Minimal Residua... Donor Lymphocyt... Hematopoietic S... Relapse | donor lymphocyt... | 14 Years - 65 Years | Nanfang Hospital, Southern Medical University | |
| Lenalidomide After Allo-Hematopoietic Cell Transplant (HCT) in Acute Myelogenous Leukemia (AML) and Myelodysplastic Syndromes (MDS) Subjects With Minimal Residual Disease | NCT02370888 | Leukemia, Myelo... Myelodysplastic... | Lenalidomide | 18 Years - | University of Florida | |
| A Study Comparing Allogeneic Hematopoietic Cell Transplantation Versus Best Available Standard of Care Therapy in Elderly Patients With Acute Myeloid Leukemia | NCT04822766 | Acute Myeloid L... | Hematopoietic s... Best chemothera... | 65 Years - 75 Years | Assistance Publique - Hôpitaux de Paris | |
| HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD Prophylaxis | NCT06001385 | Acute Lymphobla... Acute Myeloid L... Acute Leukemia Myelodysplastic... Chronic Myeloid... Chronic Lymphoc... Myeloproliferat... Lymphoma Chronic Myelomo... Pro-Lymphocytic... Myelofibrosis | Busulfan Fludarabine PBSC Hematopoie... Post-Transplant... Mesna Tacrolimus Mycophenolate M... Patient Reporte... Melphalan Total-body irra... Cyclophosphamid... | 18 Years - | Center for International Blood and Marrow Transplant Research | |
| Characteristics and Dynamics of TCR Repertoire in Patients With Hematological Malignancies After Allo-HSCT | NCT03575767 | Hematologic Neo... Hematopoietic S... Graft Vs Host D... Recurrence | Myeloablative H... | 12 Years - 55 Years | Affiliated Hospital to Academy of Military Medical Sciences | |
| The "Light for the Brain" Study | NCT02677987 | Hematopoietic S... Cognitive Impai... Sleep Depression Fatigue Quality of Life | Intervention sy... Comparison syst... | 21 Years - | Northwestern University | |
| Pharmacokinetics of Intravenous Acyclovir in Oncologic Paediatric Patients | NCT05198570 | Herpesviridae I... Herpes Simplex ... Varicella Zoste... Transplantation... Oncology | Pharmacokinetic... | 6 Months - 18 Years | University of Pisa | |
| Sorafenib Maintenance for Prophylaxis of Leukemia Relapse in Allo-HSCT Recipients With FLT3 Negative Acute Leukemia | NCT04674345 | Acute Leukemia Relapse Hematopoietic S... | Sorafenib | 18 Years - 65 Years | Nanfang Hospital, Southern Medical University | |
| Photobiomodulation for Oral Mucositis and Functional Impairments During Hematopoietic Stem Cell Transplantation | NCT06260111 | Hematologic Can... | Photobiomodulat... Usual care | 18 Years - 70 Years | Universidad del Desarrollo | |
| ALL SCTped FORUM - Pharmacogenomic Study (add-on Study) | NCT02670564 | Acute Lymphobla... | Pharmacogenomic... Busulfan plasma... | - 18 Years | Swiss Pediatric Oncology Group | |
| Cryotherapy for Prevention of Oral Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation | NCT01789658 | Oral Mucositis Pain Infection Nutrition Aspec... | Cryotherapy | 4 Years - 18 Years | Uppsala University | |
| Haploidentical Hematopoietic Stem Cell Transplantation for Acute Leukemias | NCT02759822 | Leukemia, Myelo... Precursor Cell ... | Haploidentical ... | 1 Year - 60 Years | Instituto Nacional de Cancer, Brazil | |
| Chemo Sensitization Before Hematopoietic Stem Cell Transplantation in Patients With Acute Leukemia in Complete Remission | NCT02605460 | Acute Myeloid L... Acute Lymphoid ... | Busulfan Cyclophosphamid... CXCR4 Antagonis... Hematopoietic S... | 18 Years - 60 Years | Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | |
| Screening for Colonization With Resistant Enterobacterales in Neutropenic Patients With Hematologic Malignancies | NCT04710212 | Hematologic Mal... Leukemia, Acute Neutropenia Bloodstream Inf... | No intervention... | 18 Years - | Duke University | |
| Ixazomib in the Prophylaxis of Chronic Graft-versus-host Disease. | NCT03225417 | Hematopoietic S... Multiple Myelom... | Ixazomib Tacrolimus Sirolimus Any prophylaxis... | 18 Years - | Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | |
| Efficacy Study of Ramosetron in the Setting of Hematopoietic Stem Cell Transplantation | NCT01788605 | Hematologic Mal... | ramosetron | 18 Years - | The Catholic University of Korea | |
| In-Vitro Studies in Depletion of Haplotype Mismatched Alloreactive T Cells | NCT00731705 | Hematologic Mal... Hematopoietic S... | collection of p... | 18 Years - | Indiana University | |
| Trial of GVHD Prophylasxis With PTCy or Thymoglobulin in Unrelated SCT | NCT02627573 | Leukemia, Chron... Myelodysplastic... Leukemia, Myelo... | Unrelated allog... Busulfan Fludarabine mon... Tacrolimus Mycophenolate m... Cyclophosphamid... Thymoglobulin | 18 Years - 75 Years | St. Petersburg State Pavlov Medical University | |
| A Study to Evaluate the Ability of Lupron Depot to Enhance Immune Function Following Bone Marrow Transplantation | NCT00275262 | Hodgkin Disease Lymphoma, Non-H... Multiple Myelom... Mantle Cell Lym... | Leuprolide acet... Matched placebo | 18 Years - 65 Years | Abbott | |
| A Nature-Based Virtual Reality (VR) Intervention in Family Caregivers of Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients | NCT05909202 | Neoplasm Caregivers | Sham VR Active VR | 18 Years - 100 Years | National Institutes of Health Clinical Center (CC) | |
| Respiratory Syncytial Virus - RSV Protocol | NCT01502072 | Bone Marrow Tra... Infection in Ma... Respiratory Syn... Respiratory Syn... Cancer Acute Leukemia | Ribavirin Ribavirin | 18 Years - | M.D. Anderson Cancer Center | |
| Cord Blood Stem Cell Transplantation Study (COBLT) | NCT00000603 | Anemia, Aplasti... Fanconi Anemia Hematologic Dis... Leukemia Neoplasms Severe Combined... Hematopoietic S... Myelodysplastic... | stem cell trans... | - 55 Years | National Heart, Lung, and Blood Institute (NHLBI) | |
| Post-transplantation Cyclophosphamide as GVHD Prophylaxis After HSCT | NCT02294552 | Acute Myeloid L... Acute Lymphoid ... Lymphoma Myelodysplastic... Chronic Lymphoc... Immune System D... | Cyclophosphamid... Busulfan Fludarabine mon... Tacrolimus Mycophenolate m... Allogeneic hema... | 18 Years - 65 Years | St. Petersburg State Pavlov Medical University | |
| Immunomonitoring After Hematopoietic Stem Cell Transplantation | NCT04635397 | Hematopoietic S... | 18 Years - | Centre Hospitalier Universitaire de Nice | ||
| Associations Between Pre-transplant Comorbidities and Post-transplant Toxicities and Quality of Life | NCT01930981 | Hematologic Mal... Other Diagnoses... | 19 Years - | Fred Hutchinson Cancer Center | ||
| A Research Study of Bone Marrow Transplantation From Unrelated or Partially Matched Related Donors | NCT01349101 | Hematological M... | Total Body Irra... Cyclophosphamid... Tacrolimus Mycophenolate m... Fludarabine Busulfan Hematopoietic s... | 18 Years - | Thomas Jefferson University | |
| Reduction of Cord Blood Transplantation Toxicity in Patients With Acute Myeloid Leukemia | NCT00797758 | Acute Myeloid L... | Cord blood tran... | 4 Years - 65 Years | Assistance Publique - Hôpitaux de Paris | |
| Haploidentical Stem Cell Transplantation in Neuroblastoma | NCT00790413 | Neuroblastoma | iodine I 131 me... Fludarabine Thiotepa T-cell depletio... Haploidentical ... Donor Lymphocyt... Rituximab Co-transplantat... | 6 Months - 21 Years | Lund University Hospital | |
| Precision-T: A Randomized Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies | NCT05316701 | Acute Myeloid L... Acute Lymphoid ... Mixed Phenotype... Undifferentiate... Myelodysplastic... Acute Leukemia Therapy-Related... | Orca-T Standard-of-Car... | 18 Years - 65 Years | Orca Biosystems, Inc. | |
| Haploidentical Hematopoietic Stem Cell Transplantation for Acute Leukemias | NCT02759822 | Leukemia, Myelo... Precursor Cell ... | Haploidentical ... | 1 Year - 60 Years | Instituto Nacional de Cancer, Brazil |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
